Antibody reactivity against EBNA1 and GlialCAM differentiates multiple sclerosis patients from healthy controls - Neda Sattarnezhad; Ingrid Kockum; Olivia G. Thomas; Yicong Liu; Peggy P. Ho; Alison K. Barrett; Alexandros I. Comanescu; Tilini U. Wijeratne; Paul J. Utz; Lars Alfredsson; Lawrence Steinman; William H. Robinson; et al. (Proceedings of the National Academy of Sciences, 2025)